BFEC
CGEN icon

Benjamin F. Edwards & Company’s Compugen CGEN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-200
Closed – – 1766
2023
Q1 		$0 Sell
200
-2,000
-91% -$1.65K ﹤0.01% 1798
2022
Q4 		$2K Sell
2,200
-720
-25% -$628 ﹤0.01% 1715
2022
Q3 		$2K Hold
2,920
– – ﹤0.01% 1698
2022
Q2 		$5K Sell
2,920
-300
-9% -$648 ﹤0.01% 1526
2022
Q1 		$11K Sell
3,220
-2,480
-44% -$8.37K ﹤0.01% 1336
2021
Q4 		$25K Sell
5,700
-4,100
-42% -$22.2K ﹤0.01% 1187
2021
Q3 		$59K Sell
9,800
-900
-8% -$6.03K ﹤0.01% 984
2021
Q2 		$89K Sell
10,700
-11,000
-51% -$89.3K ﹤0.01% 871
2021
Q1 		$186K Sell
21,700
-21,700
-50% -$241K 0.01% 695
2020
Q4 		$526K Hold
43,400
– – 0.03% 416
2020
Q3 		$705K Buy
43,400
+38,200
+735% +$626K 0.05% 336
2020
Q2 		$78K Sell
5,200
-5,700
-52% -$76.9K 0.01% 798
2020
Q1 		$79K Sell
10,900
-350
-3% -$2.75K 0.01% 753
2019
Q4 		$67K Sell
11,250
-23,450
-68% -$121K ﹤0.01% 901
2019
Q3 		$147K Sell
34,700
-28,500
-45% -$107K 0.01% 640
2019
Q2 		$243K Sell
63,200
-63,100
-50% -$223K 0.02% 486
2019
Q1 		$523K Sell
126,300
-11,400
-8% -$39.1K 0.05% 323
2018
Q4 		$299K Sell
137,700
-27,900
-17% -$88.4K 0.03% 398
2018
Q3 		$638K Sell
165,600
-2,000
-1% -$7K 0.06% 292
2018
Q2 		$553K Buy
167,600
+42,900
+34% +$161K 0.05% 307
2018
Q1 		$534K Buy
124,700
+39,400
+46% +$133K 0.05% 318
2017
Q4 		$213K Buy
85,300
+22,305
+35% +$66.4K 0.02% 470
2017
Q3 		$239K Buy
62,995
+5,310
+9% +$18.4K 0.03% 415
2017
Q2 		$219K Sell
57,685
-8,615
-13% -$35.8K 0.03% 415
2017
Q1 		$285K Buy
66,300
+3,600
+6% +$16.6K 0.04% 344
2016
Q4 		$320K Buy
62,700
+15,050
+32% +$90.1K 0.05% 299
2016
Q3 		$300K Buy
47,650
+22,300
+88% +$151K 0.05% 288
2016
Q2 		$164K Buy
+25,350
New +$169K 0.03% 338

Other funds holding CGEN

TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Antonetti Capital Management Naples, Florida $64M AUM 3.84% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Benjamin F. Edwards & Company's CGEN Position: Q2 2023 in Review

Benjamin F. Edwards & Company sold out of Compugen (CGEN) in Q2 2023, closing a stake of 200 shares.

Benjamin F. Edwards & Company first reported a position in CGEN in Q2 2016 and held it in 28 quarters. The position peaked at $705K in Q3 2020. 68 funds tracked by Wall St. Rank hold CGEN as of Q2 2023.

  • Benjamin F. Edwards & Company reported no remaining Compugen position as of Q2 2023 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 200 Compugen shares in Q2 2023.
  • Benjamin F. Edwards & Company first reported a position in Compugen in Q2 2016 and held it in 28 quarters.
  • Benjamin F. Edwards & Company's Compugen position peaked at $705K in Q3 2020.
  • 68 funds tracked by Wall St. Rank held Compugen as of Q2 2023.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2023, filed 15 Aug 2023.